Opportunity Information: Apply for CDC RFA GH17 1701
This funding opportunity, titled "Global Measles and other Vaccine Preventable Disease Activities" (Funding Opportunity Number: CDC RFA GH17-1701), is a CDC-led cooperative agreement designed to support international measles and rubella control and elimination efforts, with a strong operational focus on helping priority countries access the tools and expertise needed to reduce transmission and move toward elimination. The program centers on facilitating the provision of measles-containing vaccine (MCV) and measles-and-rubella-containing vaccine (MRCV), along with the practical support systems that make vaccination campaigns safe, feasible, and effective in real-world settings.
A key feature of the announcement is its emphasis on providing "bundled" vaccine. In this context, bundled means the vaccine itself plus the associated injection supplies and waste-management materials required for safe delivery, including the items needed to ensure safe injections and the safe disposal of vaccine vials and used injection materials. This framing highlights that success is not just about purchasing doses, but also about ensuring that countries can administer them safely at scale and manage medical waste appropriately, which is essential for maintaining public trust, preventing needle-related harms, and meeting basic infection prevention standards.
The activities supported under the award span several core technical areas. One major component is vaccine procurement and maintaining global availability of supply, meaning the effort is not limited to buying vaccines for a single setting but also considers broader supply reliability and access for countries that are prioritized for measles and rubella control. Another major component is surveillance, specifically to better define and assess which countries remain endemic for measles and rubella and to track progress and gaps over time. Strong surveillance is positioned as a foundational requirement because elimination goals depend on timely case detection, accurate classification of transmission patterns, and the ability to rapidly identify outbreaks and immunity gaps.
The opportunity also prioritizes laboratory capacity, including building and strengthening a global laboratory network capable of measles and rubella serologic diagnosis and virus isolation, particularly in developing countries. This laboratory network element is important because confirming cases, differentiating measles from rubella and other rash illnesses, and characterizing virus strains are central to understanding transmission dynamics, documenting interruption of endemic transmission, and guiding targeted responses. Laboratory confirmation and standardized testing networks also help ensure that surveillance data is comparable across countries and over time.
In addition, the announcement supports direct assistance to foreign governments in planning and implementing large-scale immunization activities such as national immunization days, along with other measles and rubella control interventions. This includes programmatic support and the use of technical experts and consultants as needed, reflecting that the work often requires specialized planning for logistics, cold chain management, campaign microplanning, social mobilization, data management, and post-campaign evaluation. The cooperative agreement structure implies active collaboration with CDC rather than a purely hands-off grant, with CDC and the recipient coordinating to deliver agreed-upon technical and operational outcomes.
While the main emphasis is measles and rubella, the FOA also allows, as agreed by CDC and the United Nations Foundation (UNF), support for efforts that strengthen routine immunization (RI) delivery systems and capacity in developing countries. This is presented as a way to help countries reach globally agreed vaccine-preventable disease goals across control, elimination, and eradication initiatives. In practice, this signals that the award can support not only campaign-style vaccination pushes but also improvements to the underlying immunization system that sustains high coverage over time, which is critical to preventing resurgence after campaigns end.
From an administrative standpoint, the opportunity is categorized as discretionary funding and uses a cooperative agreement instrument. It falls under the health funding activity category and lists CFDA number 93.318. Eligible applicants include nonprofit organizations with 501(c)(3) status (excluding institutions of higher education), nonprofits without 501(c)(3) status (also excluding institutions of higher education), and other eligible entities as defined by the announcement. The issuing agency is the Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH). The posting indicates an expected number of awards of one, suggesting a single primary awardee to coordinate and deliver the package of procurement and technical assistance activities. The original closing date listed is March 15, 2017, and the record creation date is December 12, 2016. The United Nations Foundation is referenced with an address in Washington, DC, indicating a role tied to coordination or implementation arrangements described in the opportunity.Apply for CDC RFA GH17 1701
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Global Measles and other Vaccine Preventable Disease Activities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on 2016-12-12.
- Applicants must submit their applications by 2017-03-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Global Measles and other Vaccine Preventable Disease Activities" and the Funding Opportunity Number is CDC RFA GH17-1701.
Which federal agency is issuing this funding opportunity?
The issuing agency is the Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH).
What type of funding mechanism is being used?
This opportunity uses a cooperative agreement instrument. It is also categorized as discretionary funding.
What does a cooperative agreement imply for how the work will be carried out?
The cooperative agreement structure implies active collaboration with CDC rather than a purely hands-off grant. CDC and the recipient coordinate to deliver agreed-upon technical and operational outcomes.
What is the main purpose of this funding opportunity?
The purpose is to support international measles and rubella control and elimination efforts. The program has a strong operational focus on helping priority countries access tools and expertise to reduce transmission and move toward elimination.
Which diseases are the primary focus of the program?
The main emphasis is measles and rubella, including activities that support their control and elimination.
Does the opportunity include work beyond measles and rubella?
Yes. While measles and rubella are the primary focus, the announcement also allows (as agreed by CDC and the United Nations Foundation) support for efforts that strengthen routine immunization (RI) delivery systems and capacity in developing countries to help reach broader vaccine-preventable disease goals.
What does "bundled" vaccine mean in this announcement?
"Bundled" vaccine means the vaccine itself plus the associated injection supplies and waste-management materials required for safe delivery. This includes items needed for safe injections and the safe disposal of vaccine vials and used injection materials.
Why does the opportunity emphasize bundled vaccine rather than vaccine doses alone?
The framing highlights that success is not only about purchasing doses. It also depends on the ability to administer vaccine safely at scale and manage medical waste appropriately, which supports infection prevention standards, reduces needle-related harms, and helps maintain public trust.
Which vaccine types are specifically referenced?
The announcement references measles-containing vaccine (MCV) and measles-and-rubella-containing vaccine (MRCV).
What core technical areas are supported by the award?
Supported areas include vaccine procurement and maintaining global availability of supply, surveillance to define and assess endemic status and track progress, laboratory capacity and a global lab network for diagnosis and virus isolation, and direct assistance to foreign governments for planning and implementing large-scale immunization activities and other control interventions.
What does vaccine procurement and "global availability of supply" mean in this context?
The program includes vaccine procurement and efforts to maintain reliable global availability of vaccine supply. The focus is not limited to a single setting; it considers broader supply reliability and access for priority countries working on measles and rubella control.
What surveillance activities are included?
The opportunity supports surveillance to better define and assess which countries remain endemic for measles and rubella and to track progress and gaps over time.
Why is surveillance described as foundational for elimination goals?
Elimination goals depend on timely case detection, accurate classification of transmission patterns, and rapid identification of outbreaks and immunity gaps.
What laboratory-related activities are supported?
The announcement supports building and strengthening a global laboratory network capable of measles and rubella serologic diagnosis and virus isolation, particularly in developing countries.
Why is laboratory capacity important for measles and rubella elimination efforts?
Laboratory confirmation helps confirm cases, differentiate measles from rubella and other rash illnesses, and characterize virus strains. This supports understanding transmission dynamics, documenting interruption of endemic transmission, and guiding targeted responses. Standardized networks also help make surveillance data comparable across countries and over time.
What kinds of on-the-ground immunization activities may be supported?
The opportunity supports direct assistance to foreign governments in planning and implementing large-scale immunization activities such as national immunization days, along with other measles and rubella control interventions.
Does the announcement mention the use of technical experts or consultants?
Yes. It includes programmatic support and the use of technical experts and consultants as needed.
What types of operational or program support are implied for large-scale campaigns?
The description points to specialized planning needs such as logistics, cold chain management, campaign microplanning, social mobilization, data management, and post-campaign evaluation.
Is routine immunization system strengthening eligible under this opportunity?
Yes, the FOA allows support for strengthening routine immunization delivery systems and capacity in developing countries, as agreed by CDC and the United Nations Foundation.
How many awards does CDC expect to make under this opportunity?
The posting indicates an expected number of awards of one, suggesting a single primary awardee to coordinate and deliver the package of procurement and technical assistance activities.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.318.
What is the funding activity category?
It falls under the health funding activity category.
Who is eligible to apply based on the information provided?
Eligible applicants include nonprofit organizations with 501(c)(3) status (excluding institutions of higher education), nonprofits without 501(c)(3) status (also excluding institutions of higher education), and other eligible entities as defined by the announcement.
Are institutions of higher education eligible?
The eligibility language provided excludes institutions of higher education for the listed nonprofit categories.
What is the closing date for the opportunity?
The original closing date listed is March 15, 2017.
When was the grant record created?
The record creation date is December 12, 2016.
What role does the United Nations Foundation (UNF) appear to have in this opportunity?
The United Nations Foundation is referenced in connection with coordination or implementation arrangements described in the opportunity, including that certain routine immunization system strengthening efforts may be supported as agreed by CDC and UNF.
Is an address provided for the United Nations Foundation?
Yes. The opportunity references the United Nations Foundation with an address in Washington, DC.
Does the opportunity specify which countries are targeted?
The description refers to "priority countries" and emphasizes developing countries, but it does not list specific countries in the information provided.
What is meant by helping countries "access the tools and expertise needed"?
Based on the description, this includes facilitating access to vaccines (including bundled supplies) and providing practical technical and operational support systems that make vaccination campaigns safe, feasible, and effective in real-world settings.
Does this opportunity focus only on vaccination campaigns?
No. It supports large-scale immunization activities (including national immunization days) and also allows support for strengthening routine immunization systems, which helps sustain high coverage beyond campaign periods.
Browse more opportunities from the same category: Health
Next opportunity: 2017 NCS-X Implementation Assistance Program: Phase IV - Support for State Programs
Previous opportunity: Region 10 Fiscal Year 2023/2024 Wetland Program Development Grants
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH17 1701
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH17 1701) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening HIV/AIDS Research in Kenya Apply for RFA PS 17 005 Funding Number: RFA PS 17 005 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,500,000 |
| NGO Polio Eradication Project Apply for RFA OAA 17 000003 Funding Number: RFA OAA 17 000003 Agency: Agency for International Development Category: Health Funding Amount: $74,000,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya under the President’s Emergency Plan for AI Apply for CDC RFA GH16 161902CONT17 Funding Number: CDC RFA GH16 161902CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting the implementation, expansion, sustainability and ownership of high quality HIV services in Siaya County in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 169102CONT17 Funding Number: CDC RFA GH16 169102CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&# Apply for CDC RFA GH16 171602CONT17 Funding Number: CDC RFA GH16 171602CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Increasing access to and availability of sustainable, high quality, comprehensive and evidence-based behavioral, biomedical and structural HIV prevention services among key populations and priority populations in Nairobi, Central and Eastern regions Apply for CDC RFA GH16 171702CONT17 Funding Number: CDC RFA GH16 171702CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting Implementation of Comprehensive HIV Prevention, Care and Treatment Programs in Bomu Hospital Affiliated Sites, Coptic Hospitals, and Faith-Based Sites in the Eastern Slums of Nairobi, Kenya under the President’s Emergency Plan for AI Apply for CDC RFA GH16 169002CONT17 Funding Number: CDC RFA GH16 169002CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Eastern South Region and Nairobi County of the Republic of Kenya under the President’s Emergency Plan Apply for CDC RFA GH16 170102CONT17 Funding Number: CDC RFA GH16 170102CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting the Provision of High Quality, Comprehensive, and Sustainable HIV Services in National Teaching and Referral Hospitals in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 162102CONT17 Funding Number: CDC RFA GH16 162102CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Partnership with the Ministry of Health to accelerate sustainable, high quality HIV/AIDS and TB programs and achieve epidemic control in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 162702CONT17 Funding Number: CDC RFA GH16 162702CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting the Ministry of Health, County Health Management Teams, and service delivery partners in developing and maintaining Health Information Systems Innovations in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA GH16 162802CONT17 Funding Number: CDC RFA GH16 162802CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 163402CONT17 Funding Number: CDC RFA GH16 163402CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Comprehensive Approaches to Strengthening the Health System and HIV response in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA GH15 155603CONT17 Funding Number: CDC RFA GH15 155603CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention a Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease Apply for RFA CK 14 00504CONT17 Funding Number: RFA CK 14 00504CONT17 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations Apply for RFA IP 15 00203CONT17 Funding Number: RFA IP 15 00203CONT17 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| CDC-Mexico Cooperative Agreement for Surveillance, Epidemiology, and Laboratory Capacity Apply for CDC RFA CK17 1707 Funding Number: CDC RFA CK17 1707 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Building Capacity of the Public Health System to Improve Population Health through National, Nonprofit Organizations Apply for CDC RFA OT13 13020401SUPP17 Funding Number: CDC RFA OT13 13020401SUPP17 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: $914,757 |
| Strengthening the Public Health System in the U.S.-Affiliated Pacific Islands Apply for CDC RFA OT16 16010101SUPP17 Funding Number: CDC RFA OT16 16010101SUPP17 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: $150,000 |
| Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease Apply for CDC RFA OE17 1702 Funding Number: CDC RFA OE17 1702 Agency: Centers for Disease Control - CSELS Category: Health Funding Amount: $921,500 |
| Centers for Disease Control and Prevention Collaboration on Climate Sensitive Diseases and Health Effects Solicitation for FY2014 Noncompetitive Continuation Application Apply for RFA CK 14 00304CONT17 Funding Number: RFA CK 14 00304CONT17 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH17 1701", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.